Search results
EDITORIAL: Capping Colorado’s prescription costs will backfire
Colorado Springs Gazette· 19 hours agoIf only there were a magic wand to tame the high cost of living in our inflationary economy. Thus,...
OPINION: My patients can’t afford two crucial medications, and Big Pharma should be held accountable
Montrose Daily Press· 6 days agoAs a physician, I am encouraged and impressed with the work that Colorado’s Prescription Drug...
Earnings Season Update and Analyst Reports for Broadcom, JNJ & Verizon
Zacks via Yahoo Finance· 3 days agoToday's Research Daily features an earnings season update and new research reports on Broadcom...
AbbVie's Arthritis Drug Humira Retains Market Dominance Despite Biosimilar Competition, Challenges...
Benzinga· 7 days agoAbbVie Inc’s ABBV top-selling arthritis drug, Humira, has managed to retain over 80% of its patients even after facing nine lower-priced rivals in the U.S. over the past year, Reuters reports ...
AbbVie's tight grip on Humira market raises concerns about biosimilars
Reuters via Yahoo News· 7 days agoAbbVie’s top-selling arthritis drug Humira has held onto more than 80% of patients after facing nine...
It’s time we stop corporate pharmaceutical companies from using their power to rig the rules - The...
The Boston Globe· 4 days agoMost Rhode Islanders agree that everyone, no matter where they come from or how much money they...
State Drug Pricing Boards Forge Ahead With Eyes on Amgen Suit
Bloomberg Law· 4 days agoState affordability boards seeking to limit what health plans pay for prescription drugs are confident they will withstand legal challenges as Colorado battles what’s expected to be the first ...